Evolvere BioSciences

Evolvere BioSciences YC Application

Summer 2024Active

Evolvere BioSciences went through Y Combinator in the Summer 2024 batch as a Healthcare company. Below: what the company does, who founded it, and its application to YC, reconstructed question by question in the real YC form.

YC batch
Summer 2024
Industry
HealthcareTherapeutics
Team size
3
Status
Active
Launched
2024

Founders

  • Adam Winnifrith
    Adam WinnifrithFounder
  • Piotr Jedryszek
    Piotr JedryszekFounder
  • Weronika Slesak
    Weronika SlesakFounder

What Evolvere BioSciences does

🦠🤖 We use our computational models to make next-generation antibiotics that outcompete bacterial evolution and precisely target pathogenic bacteria, without harming good microbes or human cells. ☠️ Current antibiotics stop working because bacteria evolve resistance to them. This makes drug-resistant bacteria a looming global health crisis - already killing more people than malaria and AIDS and it is getting exponentially worse 📈. 🧬 Our approach leverages co-evolutionary protein-protein interaction datasets combined with AI to forecast bacterial mutations and create ‘future-proof’ antibiotics, addressing antibiotic resistance before it develops. This changes the game for how frequently society will need to make new antibiotics and how long our new antibiotics will be able to treat patients 👩‍⚕️. We are a team of biochemists and evolutionary biologists who met at the University of Oxford.

Evolvere BioSciences's YC application, reconstructed

Y Combinator application

Evolvere BioSciences, Summer 2024 batch. The real form questions, answered from public data.

  1. Founders2
  2. Company7
  3. Progress7
  4. Idea4
  5. Equity3
  6. Curious2
  7. Batch Preference1

Company

Company name

Evolvere BioSciences

Describe what your company does in 50 characters or less.

Next-gen antibiotics outpace bacterial resistance

What is your company going to make? Please describe your product and what it does or will do.

We build computational models that predict how bacteria will evolve resistance to antibiotics. Using those forecasts, we design antibiotics that bacteria can't easily outsmart, targeting only harmful bacteria and sparing beneficial microbes and human cells.

Where do you live now, and where would the company be based after YC?

We live in Oxford, England, and would base the company there after YC.

Explain your decision regarding location.

We're rooted in Oxford because we met here at the University of Oxford as biochemists and evolutionary biologists. The region's scientific environment and access to expertise are vital for our work.

21 more answers in the full application

Founders, Progress, Idea, Equity, Curious, Batch Preference are in the full version. Create a free account to open it in YC Insights, next to every other YC batch.

Frequently Asked Questions

Is this the real Evolvere BioSciences YC application?

No. Y Combinator keeps submitted applications private. This is a reconstruction: the real YC form questions, answered from Evolvere BioSciences's public data (launch notes, founder backgrounds, product description). It shows how a company like Evolvere BioSciences would present itself to YC, not the text they submitted.

What YC batch was Evolvere BioSciences in?

Evolvere BioSciences was part of the Y Combinator Summer 2024 batch.

Who founded Evolvere BioSciences?

Evolvere BioSciences was founded by Adam Winnifrith, Piotr Jedryszek, Weronika Slesak.

What does Evolvere BioSciences do?

Making Next-Generation Antibiotics that Outpace Bacterial Evolution

How do I read the full reconstructed application?

Create a free Round Funded account. The full 26-answer version of Evolvere BioSciences's application, and every other YC batch, is in YC Insights.

More YC startups like Evolvere BioSciences